Release Date: 27/09/19 16:30 Summary: Corporate Governance statement and Appendix 4G Price Sensitive: No Download Document 361.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%